Annual Revenue
$396.59 M
+$321.17 M+425.83%
December 31, 2023
Summary
- As of February 7, 2025, APLS annual revenue is $396.59 million, with the most recent change of +$321.17 million (+425.83%) on December 31, 2023.
- During the last 3 years, APLS annual revenue has risen by +$145.94 million (+58.23%).
- APLS annual revenue is now at all-time high.
Performance
APLS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$196.83 M
-$2.85 M-1.43%
September 30, 2024
Summary
- As of February 7, 2025, APLS quarterly revenue is $196.83 million, with the most recent change of -$2.85 million (-1.43%) on September 30, 2024.
- Over the past year, APLS quarterly revenue has increased by +$50.45 million (+34.47%).
- APLS quarterly revenue is now -21.27% below its all-time high of $250.00 million, reached on December 31, 2020.
Performance
APLS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$715.22 M
+$86.43 M+13.75%
September 30, 2024
Summary
- As of February 7, 2025, APLS TTM revenue is $715.22 million, with the most recent change of +$86.43 million (+13.75%) on September 30, 2024.
- Over the past year, APLS TTM revenue has increased by +$318.63 million (+80.34%).
- APLS TTM revenue is now at all-time high.
Performance
APLS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
APLS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +425.8% | +34.5% | +80.3% |
| 3 y3 years | +58.2% | +226.5% | +974.5% |
| 5 y5 years | - | +226.5% | +974.5% |
APLS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +495.8% | -1.4% | +1268.7% | at high | +974.5% |
| 5 y | 5-year | at high | +495.8% | -21.3% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | +495.8% | -21.3% | >+9999.0% | at high | >+9999.0% |
Apellis Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $196.83 M(-1.4%) | $715.22 M(+13.7%) |
| Jun 2024 | - | $199.69 M(+15.9%) | $628.79 M(+20.0%) |
| Mar 2024 | - | $172.32 M(+17.7%) | $524.07 M(+32.1%) |
| Dec 2023 | $396.59 M(+425.8%) | $146.38 M(+32.6%) | $396.59 M(+45.3%) |
| Sep 2023 | - | $110.40 M(+16.2%) | $272.88 M(+47.9%) |
| Jun 2023 | - | $94.97 M(+111.8%) | $184.53 M(+74.3%) |
| Mar 2023 | - | $44.85 M(+97.9%) | $105.89 M(+40.4%) |
| Dec 2022 | $75.42 M | $22.66 M(+2.8%) | $75.42 M(-33.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $22.06 M(+35.1%) | $113.05 M(+17.0%) |
| Jun 2022 | - | $16.32 M(+13.5%) | $96.64 M(+19.4%) |
| Mar 2022 | - | $14.38 M(-76.1%) | $80.94 M(+21.6%) |
| Dec 2021 | $66.56 M(-73.4%) | $60.29 M(+967.1%) | $66.56 M(-74.0%) |
| Sep 2021 | - | $5.65 M(+806.9%) | $256.27 M(+2.0%) |
| Jun 2021 | - | $623.00 K(-99.8%) | $251.27 M(+0.2%) |
| Dec 2020 | $250.65 M | $250.00 M(>+9900.0%) | $250.65 M(>+9900.0%) |
| Sep 2020 | - | $646.00 K | $646.00 K |
FAQ
- What is Apellis Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual revenue year-on-year change?
- What is Apellis Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly revenue year-on-year change?
- What is Apellis Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM revenue year-on-year change?
What is Apellis Pharmaceuticals annual revenue?
The current annual revenue of APLS is $396.59 M
What is the all time high annual revenue for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual revenue is $396.59 M
What is Apellis Pharmaceuticals annual revenue year-on-year change?
Over the past year, APLS annual revenue has changed by +$321.17 M (+425.83%)
What is Apellis Pharmaceuticals quarterly revenue?
The current quarterly revenue of APLS is $196.83 M
What is the all time high quarterly revenue for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly revenue is $250.00 M
What is Apellis Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, APLS quarterly revenue has changed by +$50.45 M (+34.47%)
What is Apellis Pharmaceuticals TTM revenue?
The current TTM revenue of APLS is $715.22 M
What is the all time high TTM revenue for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM revenue is $715.22 M
What is Apellis Pharmaceuticals TTM revenue year-on-year change?
Over the past year, APLS TTM revenue has changed by +$318.63 M (+80.34%)